Autologous mesenchymal stem cells (MSCs) have been approved by the US FDA for specific treatments such as arthritis in the knee or other localized points in the body. Because this treatment is relatively new, it takes time for the appropriate clinical trials to be conducted, studied, and released, and therefore not all treatments have been FDA approved yet.